Abstract
A randomized double-blind pilot trial was carried out to assess the potential beneficial effects of TetraSOD® on the semen quality of idiopathic infertile men. Forty individuals were recruited and divided into two experimental groups, receiving either 25 mg/day or 250 mg/day of TetraSOD® for 90 days. Semen volume, sperm concentration, total sperm number, progressive motility, and normal forms were determined both at the commencement (t=0) and the end (t=3 months) of the trial. Statistically significant increases in all parameters but normal forms were induced by the highest dose of TetraSOD®, revealing the potential use of this ingredient in the clinical treatment of idiopathic infertility in men.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
